Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1071617.RAA9FvAerz8t7cU5As0XRITEklELWZZ0r_lEEaXtoHyrM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1071617.RAA9FvAerz8t7cU5As0XRITEklELWZZ0r_lEEaXtoHyrM130_assertion type Assertion NP1071617.RAA9FvAerz8t7cU5As0XRITEklELWZZ0r_lEEaXtoHyrM130_head.
- NP1071617.RAA9FvAerz8t7cU5As0XRITEklELWZZ0r_lEEaXtoHyrM130_assertion description "[Here we find that nucleolin (NCL), a major nucleolar protein, posttranscriptionally regulates the expression of a specific subset of miRNAs, including miR-21, miR-221, miR-222, and miR-103, that are causally involved in breast cancer initiation, progression, and drug resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1071617.RAA9FvAerz8t7cU5As0XRITEklELWZZ0r_lEEaXtoHyrM130_provenance.
- NP1071617.RAA9FvAerz8t7cU5As0XRITEklELWZZ0r_lEEaXtoHyrM130_assertion evidence source_evidence_literature NP1071617.RAA9FvAerz8t7cU5As0XRITEklELWZZ0r_lEEaXtoHyrM130_provenance.
- NP1071617.RAA9FvAerz8t7cU5As0XRITEklELWZZ0r_lEEaXtoHyrM130_assertion SIO_000772 23610125 NP1071617.RAA9FvAerz8t7cU5As0XRITEklELWZZ0r_lEEaXtoHyrM130_provenance.
- NP1071617.RAA9FvAerz8t7cU5As0XRITEklELWZZ0r_lEEaXtoHyrM130_assertion wasDerivedFrom befree-2016 NP1071617.RAA9FvAerz8t7cU5As0XRITEklELWZZ0r_lEEaXtoHyrM130_provenance.
- NP1071617.RAA9FvAerz8t7cU5As0XRITEklELWZZ0r_lEEaXtoHyrM130_assertion wasGeneratedBy ECO_0000203 NP1071617.RAA9FvAerz8t7cU5As0XRITEklELWZZ0r_lEEaXtoHyrM130_provenance.